Dilyana N.
- Country
- Bulgaria
- Department
- Clinic of internal diseases, Nephrology department
Research Overview
- Phase III Randomized Double‑Blind Placebo‑Controlled Trial of Elecoglipron (AZD5004) on Renal Decline and Mortality in Adults with Chronic Kidney Disease
- Efficacy and Safety Evaluation of Namodenoson in Patients with Non-Alcoholic Steatohepatitis (NASH) with F1-3 Fibrosis: A Phase 2B Randomized, Double-Blind, Placebo-Controlled Study
- Efficacy and Safety of NNC0194-0499 and Semaglutide in Non-Alcoholic Steatohepatitis with Fibrosis Stages F2-F4: A Dose-Ranging, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 103 of 388 partner sites.
Specializations
Liver Disease Expertise
This investigator specializes in treating complex liver conditions, with particular emphasis on non-alcoholic steatohepatitis (NASH) and its various manifestations including liver fibrosis. Their research encompasses both cirrhotic and non-cirrhotic presentations of the disease.
- NASH with liver fibrosis
- Metabolic dysfunction-associated steatohepatitis (MASH)
- Compensated cirrhosis
Their work extends to investigating innovative therapeutic approaches for liver fibrosis regression and prevention of disease progression.
Metabolic Liver Disorders
The investigator focuses on the treatment of metabolic liver diseases, particularly exploring combination therapies and novel therapeutic agents. Their expertise includes evaluating treatments for various stages of liver fibrosis and metabolic dysfunction.
- Primary biliary cholangitis
- Metabolic dysfunction-associated liver conditions
- Progressive liver fibrosis
Their research involves assessing both single-agent and combination therapeutic approaches for metabolic liver disorders.
Viral Hepatitis Management
The investigator has developed expertise in treating chronic viral hepatitis, with specific focus on hepatitis D virus infection. Their work involves evaluation of novel therapeutic agents for viral liver diseases.
- Chronic hepatitis D infection
- Viral liver disease therapies
- Liver disease progression monitoring
Their research encompasses safety and efficacy evaluations of emerging antiviral treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.